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 Introduction
Botulism is caused by the bacterium Clostridium (C.)
tulinum and is usually an intoxication in humans and
o in animals, when the C. botulinum neurotoxins
oNT) are ingested with contaminated food or feedstuff,
respectively (Hatheway, 1990). So far, seven serologically
differentiable toxin types (A–G) are known, a new serotype
H was proposed recently which remains to be veriﬁed
(Rossetto et al., 2014). Serotypes A, B, E and F are causing
human and animal botulism, whereas types C and D are
reported to cause predominantly animal botulism (Lind-
strom and Korkeala, 2006; Lindstrom et al., 2010).
Furthermore, BoNT serotypes are divided into subtypes
based on their nucleic acid and amino acid sequence
heterogeneity (Hill and Smith, 2013). Remarkable mor-
phological and physiological differences are seen between
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A B S T R A C T
Botulism caused by neurotoxins of Clostridium (C.) botulinum is a rare, but serious life-
threatening disease in humans and animals. Botulism in livestock is usually caused by the
oral uptake of C. botulinum neurotoxins (BoNT) via contaminated feed and is characterized
by ﬂaccid paralysis. In the recent past a new syndrome caused by BoNT in dairy cattle was
postulated. It was supposed that C. botulinum is able to colonize the lower intestine and
may subsequently produce neurotoxin. The continuous resorption of small amounts of
these BoNT may then provoke the so called syndrome of ‘‘chronic’’ or ‘‘visceral’’ botulism
involving unspeciﬁc clinical symptoms, reduced performance of dairy cows and massive
animal losses in the affected herd. To test this hypothesis a case-control study was
conducted involving 92 affected farms and 47 control farms located in Northern Germany.
Fecal samples of 1388 animals were investigated for the presence of BoNT to verify the key
requirement of the hypothesis of chronic botulism. BoNT was not detected in any of the
fecal samples using the most sensitive standard method for BoNT detection, the mouse
bioassay. Therefore, the existence of ‘‘chronic’’ or ‘‘visceral’’ botulism could not be proven.
 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
 Corresponding author. Tel.: +49 3641 804 2295;
: +49 3641 804 2228.
E-mail address: christian.seyboldt@ﬂi.bund.de (C. Seyboldt).
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hysiologically different BoNT producing groups of
. botulinum (I–IV) are described (Hatheway, 1990;
ossetto et al., 2014). Modern comparative sequence
nalysis also conﬁrms that there are signiﬁcant genetic
ifferences between these groups (Rossetto et al., 2014).
hese ﬁndings also point to the fact that at present several
ifferent Clostridium species, the common characteristic
f which is the production of orally effective neurotoxins,
re subsumed under the name C. botulinum. Additionally,
ome strains of C. baratii and C. butyricum produce
oNT of the serotypes F and E, respectively (Rossetto
t al., 2014).
BoNT are highly potent poisons and are considered to be
e most toxic substances produced by living organisms
ill, 1982). The seven known serotypes cause muscular
aralyses by blocking the release of acetylcholine at the
euromuscular synapses. Due to the complexity of their
xic effect, the detection of C. botulinum neurotoxins
epresents a considerable diagnostic challenge (Dorner
t al., 2013; Lindstrom and Korkeala, 2006). So far, BoNT
re the only known bacterial toxins which are protected
gainst environmental inﬂuences by non-toxic accompa-
ying proteins. Based on current knowledge, these
ccompanying proteins are important for maintaining
e toxicity of BoNT in the environment and during
astrointestinal passage. They also play an important role
 passing epithelial barriers (Beneﬁeld et al., 2013; Gu
t al., 2012; Lee et al., 2013, 2014).
Establishing the diagnosis bovine botulism is difﬁcult
nd mainly based on the clinical picture and the exclusion of
ifferential diagnoses (Sto¨ber, 2002). As small amounts of
oNT are sufﬁcient to cause severe disease, it is often
ifﬁcult or impossible to detect the toxin in food or feed
roducts, especially since it is not homogenously distributed
roughout the matrix. Toxin detection in serum, organs or
testinal contents is also not always successful (CDC, 1998;
atheway, 1990). As the pathogen occurs ubiquitously (Bell
nd Kyriakides, 2000; Espelund and Klaveness, 2014),
etection of C. botulinum in the environment, in organs or
 the intestinal contents is no proof of botulism. Therefore,
e detection of BoNT is a prerequisite for the laboratory
ased diagnosis of botulism. In the recent years a number of
etection methods for BoNT had been developed, one of
ese, the Endopep-MS, is demonstrating extraordinary
igh sensitivity for BoNT of several types in food (Kalb et al.,
015), but none has fully replaced the mouse bioassay
orner et al., 2013; Singh et al., 2013). The mouse bioassay
till is the most sensitive and reliable detection method for
iologically active BoNT in clinical samples. It is considered
 be the standard method for botulinum toxin detection
orldwide (Dorner et al., 2013; Lindstrom and Korkeala,
006; Singh et al., 2013).
Human foodborne botulism is well known, but other
rms of botulism are also recognized (Rossetto et al.,
014). Botulism can present as intestinal toxemia e.g. in
fant botulism, when C. botulinum colonizes the intestine
nd then releases neurotoxin, which is absorbed into the
loodstream. As a result, infants suffer from descending
otor weakness and ﬂaccid paralysis (Midura and Arnon,
976; Pickett et al., 1976). The insufﬁciently developed
intestinal ﬂora of infants up to one year may favor
colonization with C. botulinum. Spores of C. botulinum are
possibly ingested with honey (Hatheway, 1990). Infection
of wounds with C. botulinum and subsequent botulism is
known as wound botulism mainly in persons who inject
drugs (Lindstrom and Korkeala, 2006; Rossetto et al.,
2014).
A relatively common form, BoNT type C botulism, is
seen in aquatic birds, particularly wild birds (Songer,
1997), but it is sometimes also seen especially in the
summer season in domestic poultry (Songer, 1997). The
bacterium C. botulinum is widespread in the environment,
but botulism in livestock especially in cattle occurs only
sporadic (Lindstrom et al., 2010). Botulism in cattle is
mainly caused by BoNT types C and D. An association with
poultry feces or litter has been observed (Livesey et al.,
2004; Payne et al., 2011). BoNT types A and B were only
rarely diagnosed in botulism cases of cattle (Lindstrom
et al., 2010). In general, cattle intoxication is often caused
by feed products which had been contaminated with
carcasses, e.g. silages (Songer, 1997).
In addition to foodborne botulism in domestic animals,
another form of disease in cattle has been discussed
controversially. An untypical form of botulism is supposed
to be caused by the colonization of the lower intestine
with C. botulinum bacteria, subsequent production of
BoNT and continuous resorption of small amounts of
toxins resulting in chronic wasting of the affected dairy
herd involving a complex of unspeciﬁc clinical symptoms,
reduced performance and massive animal losses (Bohnel
et al., 2001). The presumed trigger is a microbial
imbalance in the digestive tract favoring the multiplica-
tion and toxin production of C. botulinum. It is assumed
that this syndrome is multifactorial. This hypothesis has
been proposed as ‘‘visceral’’ form of botulism (Bohnel
et al., 2001). Especially, a signiﬁcant number of dairy herds
affected by chronic wasting condition in Northern
Germany were suspected to suffer from ‘‘visceral’’
botulism (Bohnel and Gessler, 2012). Due to the unspeciﬁc
clinical picture, a reasonable case deﬁnition based on
clinical ﬁndings is still pending.
‘‘Visceral’’ botulism was also discussed to be a sporadic,
but severe zoonosis, when farmers or members of their
families developed illness involving neurological syn-
dromes (Dressler and Saberi, 2009).
The overall aim of this collaborative study was to
investigate the cause of chronic disease in dairy cattle
herds, which is associated with gradual wasting and can
affect entire holdings. The crucial point of the hypothesis
of ‘‘visceral’’ botulism is the production of BoNT by viable
C. botulinum bacteria in the intestine of affected animals.
The presence of BoNT in feces at detectable amounts is the
key requirement of the hypothesis of chronic botulism. In
fact, Bohnel et al. based their hypothesis on detection of
BoNT in feces of affected animals using the mouse
bioassay (Bohnel et al., 2001). Therefore, the conﬁrmation
of the presence of BoNT in the feces of affected animals
applying the most sensitive analytical method for
botulinum toxin detection i.e. the mouse bioassay can
add more certainty to the hypothesis of ‘‘visceral’’
botulism in dairy cows.
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. Study design
In order to investigate the association between chronic
speciﬁc disease (‘‘visceral’’ botulism) on cow and herd
el and the presence of BoNT in fecal samples, a case-
ntrol study was carried out.
Criteria for case farms were: (1) a markedly reduced
ilk yield (>15% over a period of at least 3 month), (2)
creased losses due to fatalities or euthanasia (>5% during
e last 12 month), (3) a markedly increased replacement
te (>35% of the herd during the last year or an increase
 > 10% compared to the year before), (4) an increased
rcentage of recumbent animals (>10% during the last
 month) and (5) the subjective impression of the farmer
 veterinarian of chronic herd health problems. Case
rms (F) had to match at least three of these ﬁve criteria
hile control farms (K) had none of these problems. Case-
farms (F1) had no history of clostridial vaccination, while
se-2-farms (F2) had been vaccinated against clostridial
seases except C. botulinum intoxication (in Germany,
stridial vaccines are available covering diseases caused
 C. perfringens type A, C. perfringens type B, C. perfringens
pe C, C. perfringens type D, C. chauvoei, C. septicum, C novyi
pe B, C. sordellii, C. haemolyticum and C. tetani). Further
iteria for all farms were no vaccination against botulism,
cording of milk production data, housing in free stalls,
d a minimum number of 30 cows in the herd.
The study area was set to Northern Germany including
e federal states of Schleswig-Holstein, Lower Saxony und
rth Rhine-Westphalia north of the federal motorway A2,
here most of ‘‘visceral’’ botulism herds were supposed to
 located (Bohnel and Gessler, 2012) and a homogeneous
rget population was apparent (Merle et al., 2012). All
rmers participated voluntarily and subscribed either by
emselves or by their veterinarians or other advisors.
igibility criteria were requested in a telephone interview
ith the farmer and were veriﬁed, where possible, based
 the milk recording data, prior to the farm visit.
Based on the hypothesis that there is an association
tween the occurrence of C. botulinum or BoNT and the
se-control status of the farm, the sample size on farm
el was assessed (conﬁdence 95%, power 80%, detect-
le odds ratios 4, prevalence of controls 50%; calculated
ing NCSS Pass1 (Hintze, 2007)) as 46 farms in non-
ccinated (F1), vaccinated (F2) and control farms (K) each.
ssible inﬂuence of seasonality was accounted for by a
lanced investigation of case and control farms over the
dy period.
During the farm visit, lactating cows and dry cows were
ored with respect to lameness (locomotion score
precher et al., 1997)), body condition (Edmonson et al.,
89), cleanliness (Cook and Reinemann, 2007) as well as
in and leg lesions (Reubold, 2003). During the herd
oring cows, which were eligible for being chosen as
spect, and control animals were preselected and marked.
 each farm, ﬁve chronically sick animals (suspect
imals) and ﬁve animals without symptoms (control
imals) were selected randomly by the study team. Each
 these 10 animals was subjected to a thorough clinical
examination including neurological examination accord-
ing to Dirksen et al. (2012), and samples of rumen content
and fecal samples were taken. The sampling and clinical
investigations at the farms were performed by veterinar-
ians of the Clinic for Cattle of the University of Veterinary
Medicine Hannover (TiHo). The study team consisted of
veterinarians with advanced clinical experiences, who
were trained additionally prior to the investigations. The
main criteria for suspect animals were emaciation and
habitus of a chronically sick animal (Dirksen et al., 2012)
and showing at least one symptom of ‘‘visceral’’ botulism
(Bohnel et al., 2001) such as reduced milk yield, locomo-
tion score  3 (Sprecher et al., 1997), paresis, paralysis,
ataxia, indigestion (constipation, diarrhea), behavioral
change (apathy), asthenia, sensory disorders (eye lid
closure reﬂex, ear reﬂex, skin reﬂex reduced or missing),
respiratory disorders, circulatory disturbance (congested
jugular vein), bulbar paralysis, chronic laminitis, retracted
abdomen, respectively. Control animals were not allowed
to show any of the mentioned symptoms and had no signs
of acute disease and a locomotion score of 1 according to
Sprecher et al. (1997).
2.2. Sampling
Fecal samples were taken from the rectum by a
veterinarian; approximately 100 ml were placed in a screw
cap sample tube (120 ml, Sarstedt, Nu¨rmbrecht) and were
then frozen at 20 8C. Frozen fecal samples were sent to the
laboratory and were kept at 20 8C until processing.
2.3. BoNT detection by mouse bioassay
As the laboratory detection of BoNT was controversially
discussed in the context of the hypothesis of ‘‘visceral’’
botulism, a protocol for the mouse bioassay was applied
which was developed in collaboration with four German
laboratories in a laboratory comparative test effort
(Dlabola et al., 2013) to achieve maximum speciﬁcity
and sensitivity. Twenty g of fecal sample were mixed with
20 ml of gelatin buffer (2 g/l gelatin, 4 g/l Na2HPO4) in ﬁlter
bags and homogenized in a paddle blender (Stomacher,
Seward, UK). The mixture was stored at 4 8C over night to
extract the toxins. The mixture was centrifuged
(10,000  g) to remove particles and was then sterile
ﬁltered (0.20 mm Minisart High Flow syringe ﬁlter,
Sartorius, Germany). Two mice each were injected
intraperitoneally with 0.5 ml extract which was diluted
1:2 in gelatin buffer. Two further mice were injected with
trypsin treated extract (to activate potentially inactive
BoNT of some types (Cook et al., 1998)) which was also
diluted 1:2 with gelatin buffer. Another two mice received
extract (1:2 in gelatin buffer) which was heated to 100 8C
for 10 min as control, because BoNT is inactivated by this
heat treatment. The mice were then observed for BoNT
speciﬁc symptoms like wasp waist, labored abdominal
breathing, paralysis and death within four days. In case of
BoNT speciﬁc symptoms and death, mouse bioassay
serotyping was supposed to follow in order to prove the
presence of BoNT and to determine the serotype according
to existing protocols (CDC, 1998; Cook et al., 1998). Mice
r
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C. Seyboldt et al. / Veterinary Microbiology 177 (2015) 398–402 401eceiving a neurotoxic sample and a type speciﬁc antitoxin
, B, C, D, E, and F) would survive.
The mouse bioassay was done according to the German
nimal Welfare Act with permission of the respective
uthorities (Thuringia, State Ofﬁce for Consumer Protec-
on, reg. no. 22-2684-04-04-104/11).
.4. Statistical analysis
All data collected in this study was entered in a web-
ased, relational SQL database individually designed for
e project. Data was imported either manually or via
port from Excel 2010 (Microsoft Corporation, Redmond,
ashington).
Statistical analysis was carried out using SAS 9.3 (Cary,
orth Carolina). The unit of the statistical analysis was the
rm and the animal, respectively. The case-control status
f the farm as well as that of the animals was deﬁned as
ependent variable. The mouse bioassay test results were
ualitative data and deﬁned as explanatory variables.
. Results and discussion
.1. Participating farms and animals
During May 2012 and December 2013, 287 farms
egistered for study participation of which 141 farms were
isited. As two farms were not located in the study region,
39 farms (45 F1-farms, 47 F2-farms and 47 K-farms) were
cluded in statistical analyses, whereby the predeﬁned
ample size was reached. The distribution of the farms
ccording to the federal states and epidemiological
ategory (F1, F2, K) as displayed in Table 1 reﬂects the
istribution in the target population. The over representa-
on of farms in Lower Saxony and especially in Schleswig-
olstein is due to the higher reported occurrence of
hronic wasting conditions in dairy herds at the time of
ampling. Mean herd size was higher on control farms (K:
45 cows) compared to case farms (F1: 119 cows, F2:
16 cows). Most farms had mainly Holstein Friesians, but
7 farms (3 F1, 6 F2 and 8 K) had mainly Red Holstein or
rossbreeds. Milk yield was higher on control farms
verage: K: 26.0 kg per cow and day, F1: 22.8 kg, F2:
1.7 kg) due to the ﬁrst eligibility criterion.
Identiﬁcation of ﬁve control and ﬁve suspect animals
as possible at all of the included farms. Besides the main
riteria ‘‘emaciation’’ and ‘‘habitus of a chronically sick
ow’’, all cows fulﬁlled at least one further criterion. Most
uspect cows were lame with a locomotion score  3
(n = 571, 82.2%). Moreover, circulatory disturbances
(n = 206, 29.6% of suspect cows), a reduced milk yield
compared to pen average (n = 122, 17.6%), and retracted
abdomen (n = 115, 16.5%) were assessed frequently. Also,
indigestion (constipation, diarrhea) and respiratory dis-
orders were diagnosed in 66 cows (9.5%) and 44 cows
(6.3%), respectively. Neurologic disorders (paresis, paraly-
sis, ataxia), sensory disorders, neurological disorders
describing a bulbar paralysis like decreased reﬂexes at
the head, and behavioral changes were assessed in less
than 5% of suspect cows.
3.2. Detection of C. botulinum neurotoxin
1388 fecal samples (the fecal sample of one animal was
not available and one animal was ﬁnally excluded because
it was a heifer), were investigated for the presence of
C. botulinum neurotoxins in the mouse bioassay. BoNT was
not detected in any of the fecal samples and none of the
mice died with speciﬁc symptoms. 33 mice died with
unspeciﬁc symptoms (0.4% of 8512). It has to be kept in
mind that death without clinical signs is not adequate
evidence that botulinum toxin was present in the material
injected (CDC, 1998). Furthermore, referring to the USDA/
FSIS Microbiology Laboratory Guidebook (Cook et al.,
1998), death in the absence of neurological symptoms is
not an acceptable indication of mouse botulism; death may
be non-speciﬁcally caused by other microorganisms,
chemicals present in test ﬂuids or injection trauma. Three
samples were again tested in the mouse bioassay, because
two mice each died with unspeciﬁc symptoms. One of
these three samples revealed repeated unspeciﬁc toxicity
in the mouse bioassay, this sample was negative for BoNT
genes according to Takeshi et al. (1996) (data not shown).
In a further analysis, C. perfringens epsilon toxin gene was
detected in DNA extracted directly from the fecal sample in
a PCR according to Baums et al. (2004) (data not shown).
Even though C. perfringens epsilon toxin was not demon-
strated itself, we speculate that it could have been the
reason for the toxicity of the sample. Clinical signs in mice
evoked by epsilon toxin include depression, ataxia,
circling, dyspnea and death (Garcia et al., 2013) and these
clinical signs are not in conﬂict with unspeciﬁc mouse
deaths observed here.
The mouse bioassay was used to detect BoNT in fecal
samples. This assay is still regarded as the most sensitive
and standard method to detect BoNT in clinical samples.
The investigations of the fecal samples gave no hint for the
presence of BoNT. The mouse bioassay was also applied in
able 1
istribution of farms [n, (%)] by federal states and case-control status of farms (F1 = non-vaccinated case farm, F2 = vaccinated case farm, K = control farms).
Lower Saxony Northern Parts of
North Rhine-Westphalia
Schleswig-Holstein Total
Study population 65 (47) 7 (5) 67 (48) 139
K-farms 24 (51) 2 (4) 21 (45) 47
F1-farms 23 (51) 3 (7) 19 (42) 45
F2-farms 18 (38) 2 (4) 27 (58) 47
Target population1 13161 (60) 3756 (17) 5050 (23) 21967 = Milk producing farms; Source: Statistical ofﬁces of the federal states - agricultural census 2010, personal communication, October, 2013.
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C. Seyboldt et al. / Veterinary Microbiology 177 (2015) 398–402402e study describing ‘‘visceral’’ botulism, in which the
tection of BoNT in the feces of affected animals was the
ain point of the hypothesis (Bohnel et al., 2001). The
planation for this discrepancy can only be speculative;
rhaps the misinterpretation of unspeciﬁc mouse deaths
ay play a role. Another possibility is that ‘‘visceral’’ botulism
an extremely rare disease in cattle. The study was
oroughly planned and the criteria for case farms and
spect animals were selected according to the published
scription of the observed herd and animal symptoms, and
 the relevant study population was examined. Therefore, as
ain outcome of this study we conclude that the hypothesis
 ‘‘chronic’’ or ‘‘visceral’’ botulism could not be proven.
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